Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase

Detalhes bibliográficos
Ano de defesa: 2021
Autor(a) principal: Bernardes, Maria Tereza Carneiro Paschoal lattes
Orientador(a): Carvalho, Flávia Chiva lattes
Banca de defesa: Santos, Bruno Da Fonseca Dos, Santos, Aline Martins Dos, Neves, Juliana Dos Santos, Trevisan , Marcello Garcia
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Alfenas
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências Farmacêuticas
Departamento: Faculdade de Ciências Farmacêuticas
País: Brasil
Palavras-chave em Português:
Área do conhecimento CNPq:
Link de acesso: https://repositorio.unifal-mg.edu.br/handle/123456789/1789
Resumo: Introduction: Psoriasis is an autoimmune, inflammatory and chronic skin disease in which there is an acceleration of cell growth and proliferation, resulting in erythema and ill-defined lesions, with white and red stains and peeling of the epidermis. Methotrexate (MTX) is one of the drugs for the treatment of systemic use, but there are several side effects. Topical administration may be a strategy to vectorize the release of this drug at the site of action, but as the stratum corneum epidermis is a permeation barrier for hydrophilic drugs, it is necessary to develop vehicles that promote its penetration into the skin. Objective: To evaluate the topical effect of MTX in psoriasis using liquid- crystalline systems (CLs) and hydrogels as vehicles. Method: Study of phase behavior by constructing the ternary phase diagram combining polysorbate 80 (Tween® 80), isopropyl myristate (MIP) and MiliQ water to obtain CLs. The hydrogels tested were based on chitosan (HQS), hydroxypropylmethylcellulose phthalate (HHPMC) and alkylated carbomer (HCA). The samples were characterized by polarized light microscopy (MLP), oscillatory rheology, texture analysis (TPA), solubility of MTX, obtaining the release profile, ex vivo bioadhesion studies and in vivo tests in mice with induction of psoriatic dermatitis. Results: Systems containing surfactant / oil / water in the proportions 60/10/30 and 60/20/20 were characterized as lamellar phases (L1 and L2, respectively) and 50/10/40 and 50/20/30 as hexagonal phases ( H1 and H2, respectively). It was possible to solubilize MTX at a concentration of 2 mg / mL in the CLs and in the HCA hydrogel (pH = 7.4), and 0.1 mg / mL in the HQS hydrogel (pH = 3.5) and not solubilized in HPMCP ( pH = 4.5). Oscillatory rheology showed that hexagonal phases are more elastic than lamellar phases, and HCA with behavior similar to lamellar phases. The TPA test correlated with rheology, but ex vivo bioadhesion showed a better interaction of HCA with swine skin in relation to CLs. The release profile showed that H1 and H2 retained MTX more than L1 and L2, due to their more rigid and organized structure. HCA released more MTX showing that the gelled polymer network retains the drug less. The release profile adjusted for the Weibull mathematical model indicated that the release kinetics is fast and complex. As a proof of principle, in vivo tests showed that CLs promoted a more exacerbated inflammatory effect, but the HCA hydrogel had similar efficacy to dexamethasone. Conclusion: Although studies are still needed to understand the toxicity and safety of the systems, in in vivo tests in mice with imiquimod-induced psoriatic dermatitis, topical application of MTX may be a new approach for the treatment of psoriasis with less side effects and proven efficacy.
id UNIFAL_eab2331aaa6313bd081831721600f6c7
oai_identifier_str oai:repositorio.unifal-mg.edu.br:123456789/1789
network_acronym_str UNIFAL
network_name_str Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
repository_id_str
spelling Bernardes, Maria Tereza Carneiro Paschoalhttp://lattes.cnpq.br/3119063906096827Novaes, Rômulo DiasSantos, Bruno Da Fonseca DosSantos, Aline Martins DosNeves, Juliana Dos SantosTrevisan , Marcello GarciaCarvalho, Flávia Chivahttp://lattes.cnpq.br/42082661731008262021-03-31T18:05:03Z2021-02-22BERNARDES, Maria Tereza Carneiro Paschoal. Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase. 2021. 126 f. Tese ( Doutorado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2021.https://repositorio.unifal-mg.edu.br/handle/123456789/1789Introduction: Psoriasis is an autoimmune, inflammatory and chronic skin disease in which there is an acceleration of cell growth and proliferation, resulting in erythema and ill-defined lesions, with white and red stains and peeling of the epidermis. Methotrexate (MTX) is one of the drugs for the treatment of systemic use, but there are several side effects. Topical administration may be a strategy to vectorize the release of this drug at the site of action, but as the stratum corneum epidermis is a permeation barrier for hydrophilic drugs, it is necessary to develop vehicles that promote its penetration into the skin. Objective: To evaluate the topical effect of MTX in psoriasis using liquid- crystalline systems (CLs) and hydrogels as vehicles. Method: Study of phase behavior by constructing the ternary phase diagram combining polysorbate 80 (Tween® 80), isopropyl myristate (MIP) and MiliQ water to obtain CLs. The hydrogels tested were based on chitosan (HQS), hydroxypropylmethylcellulose phthalate (HHPMC) and alkylated carbomer (HCA). The samples were characterized by polarized light microscopy (MLP), oscillatory rheology, texture analysis (TPA), solubility of MTX, obtaining the release profile, ex vivo bioadhesion studies and in vivo tests in mice with induction of psoriatic dermatitis. Results: Systems containing surfactant / oil / water in the proportions 60/10/30 and 60/20/20 were characterized as lamellar phases (L1 and L2, respectively) and 50/10/40 and 50/20/30 as hexagonal phases ( H1 and H2, respectively). It was possible to solubilize MTX at a concentration of 2 mg / mL in the CLs and in the HCA hydrogel (pH = 7.4), and 0.1 mg / mL in the HQS hydrogel (pH = 3.5) and not solubilized in HPMCP ( pH = 4.5). Oscillatory rheology showed that hexagonal phases are more elastic than lamellar phases, and HCA with behavior similar to lamellar phases. The TPA test correlated with rheology, but ex vivo bioadhesion showed a better interaction of HCA with swine skin in relation to CLs. The release profile showed that H1 and H2 retained MTX more than L1 and L2, due to their more rigid and organized structure. HCA released more MTX showing that the gelled polymer network retains the drug less. The release profile adjusted for the Weibull mathematical model indicated that the release kinetics is fast and complex. As a proof of principle, in vivo tests showed that CLs promoted a more exacerbated inflammatory effect, but the HCA hydrogel had similar efficacy to dexamethasone. Conclusion: Although studies are still needed to understand the toxicity and safety of the systems, in in vivo tests in mice with imiquimod-induced psoriatic dermatitis, topical application of MTX may be a new approach for the treatment of psoriasis with less side effects and proven efficacy.Introdução: A psoríase é uma doença autoimune, inflamatória e crônica de pele em que há uma aceleração do crescimento e proliferação celular, resultando em eritemas e lesões de formato mal definidos, com colorações brancas e vermelhas e descamação da epiderme. O metotrexato (MTX) é um dos fármacos para o tratamento de uso sistêmico, mas há diversos efeitos colaterais. A administração tópica pode ser uma estratégia para vetorizar a liberação deste fármaco no local de ação, mas como o estrato córneo epidérmico é uma barreira de permeação de fármacos hidrofílicos, é necessário o desenvolvimento de veículos que promovam sua penetração na pele. Objetivo: Avaliar o efeito tópico do MTX na psoríase empregando como veículos sistemas líquido- cristalinos (CLs) e hidrogéis. Método: Estudo do comportamento de fases pela construção do diagrama ternário de fases combinando polissorbato 80 (Tween ® 80), miristato de isopropila (MIP) e água MiliQ para obtenção de CLs. Os hidrogéis testados foram baseados em quitosana (HQS), ftalato de hidroxipropilmetilcelulose (HHPMC) e carbômero alquilado (HCA). As amostras foram caracterizadas por microscopia de luz polarizada (MLP), reologia oscilatória, análise de textura (TPA), solubilidade do MTX, obtenção do perfil de liberação, estudos ex vivo de bioadesão e ensaios in vivo em camundongos com indução da dermatite psoriática. Resultados: Sistemas contendo tensoativo/óleo/água nas proporções 60/10/30 e 60/20/20 foram caracterizados como fases lamelares (L1 e L2, respectivamente) e 50/10/40 e 50/20/30 como fases hexagonais (H1 e H2, respectivamente). Foi possível solubilizar o MTX na concentração de 2 mg/mL nos CLs e no hidrogel de HCA (pH=7,4), e 0,1 mg/mL no hidrogel HQS (pH=3,5) e não solubilizado em HPMCP (pH=4,5). A reologia oscilatória mostrou que fases hexagonais são mais elásticas que as lamelares, e HCA com comportamento semelhante às lamelares. O teste de TPA correlacionou com a reologia, porém a bioadesão ex vivo mostrou melhor interação de HCA com a pele suína em relação aos CLs. O perfil de liberação mostrou que H1 e H2 retiveram mais o MTX que L1 e L2, devido a sua estrutura mais rígida e organizada. HCA liberou mais MTX mostrando que a rede polimérica gelificada retém menos o fármaco.O perfil de liberação ajustado para o modelo matemático de Weibull indicou que a cinética de liberação é rápida e complexa. Como prova de princípio, os testes in vivo demonstraram que os CLs promoveram um efeito inflamatório mais exacerbado, porém o hidrogel de HCA teve eficácia semelhante à dexametasona. Conclusão: Apesar de ainda ser necessário estudos para entender a toxicidade e segurança dos sistemas, nos testes in vivo em camundongos com dermatite psoriática induzida por imiquimode, a aplicação tópica do MTX pode ser uma nova abordagem para o tratamento da psoríase com menos efeitos colaterais e eficácia comprovada.application/pdfporUniversidade Federal de AlfenasPrograma de Pós-Graduação em Ciências FarmacêuticasUNIFAL-MGBrasilFaculdade de Ciências Farmacêuticasinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/4.0/Cristais líquidosMetotrexatoHidrogéisCIENCIAS DA SAUDE::FARMACIADesenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríaseinfo:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/publishedVersion-64258451559862442976006006997636413449754996reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifalinstname:Universidade Federal de Alfenas (UNIFAL)instacron:UNIFALBernardes, Maria Tereza Carneiro PaschoalLICENSElicense.txtlicense.txttext/plain; charset=utf-81987https://repositorio.unifal-mg.edu.br/bitstreams/c2fcd399-98b2-423c-bd80-b771886f3f16/download31555718c4fc75849dd08f27935d4f6bMD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849https://repositorio.unifal-mg.edu.br/bitstreams/d2afa41a-f603-478b-bda4-fa823b755a1f/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80https://repositorio.unifal-mg.edu.br/bitstreams/88b5c3a2-1073-4805-9e4f-d4c459047823/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80https://repositorio.unifal-mg.edu.br/bitstreams/930706b1-704d-4f6a-8c2d-45d7f3b2852d/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALTese de Maria Tereza Carneiro Paschoal Bernardes.pdfTese de Maria Tereza Carneiro Paschoal Bernardes.pdfapplication/pdf2917784https://repositorio.unifal-mg.edu.br/bitstreams/149e65d7-3fca-48fb-a738-4851c798d397/download017f50508d618168b421fed6a54b3014MD55TEXTTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.txtTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.txtExtracted texttext/plain103251https://repositorio.unifal-mg.edu.br/bitstreams/a6122d00-4f43-4bc9-a19e-545bbb5a9ef8/download4314cf716b11b8ef58b64c6e425277b4MD58THUMBNAILTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.jpgTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.jpgGenerated Thumbnailimage/jpeg2580https://repositorio.unifal-mg.edu.br/bitstreams/b90da601-8c4a-433e-8d17-86dc54cd4b09/download6df2fb28d2506c9bf74471ede9dd0f83MD57123456789/17892026-01-07 14:42:38.011http://creativecommons.org/licenses/by-nc-nd/4.0/open.accessoai:repositorio.unifal-mg.edu.br:123456789/1789https://repositorio.unifal-mg.edu.brRepositório InstitucionalPUBhttps://bdtd.unifal-mg.edu.br:8443/oai/requestrepositorio@unifal-mg.edu.bropendoar:2026-01-07T17:42:38Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL)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
dc.title.pt-BR.fl_str_mv Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
title Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
spellingShingle Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
Bernardes, Maria Tereza Carneiro Paschoal
Cristais líquidos
Metotrexato
Hidrogéis
CIENCIAS DA SAUDE::FARMACIA
title_short Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
title_full Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
title_fullStr Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
title_full_unstemmed Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
title_sort Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
author Bernardes, Maria Tereza Carneiro Paschoal
author_facet Bernardes, Maria Tereza Carneiro Paschoal
author_role author
dc.contributor.author.fl_str_mv Bernardes, Maria Tereza Carneiro Paschoal
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/3119063906096827
dc.contributor.advisor-co1.fl_str_mv Novaes, Rômulo Dias
dc.contributor.referee1.fl_str_mv Santos, Bruno Da Fonseca Dos
dc.contributor.referee2.fl_str_mv Santos, Aline Martins Dos
dc.contributor.referee3.fl_str_mv Neves, Juliana Dos Santos
dc.contributor.referee4.fl_str_mv Trevisan , Marcello Garcia
dc.contributor.advisor1.fl_str_mv Carvalho, Flávia Chiva
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/4208266173100826
contributor_str_mv Novaes, Rômulo Dias
Santos, Bruno Da Fonseca Dos
Santos, Aline Martins Dos
Neves, Juliana Dos Santos
Trevisan , Marcello Garcia
Carvalho, Flávia Chiva
dc.subject.por.fl_str_mv Cristais líquidos
Metotrexato
Hidrogéis
topic Cristais líquidos
Metotrexato
Hidrogéis
CIENCIAS DA SAUDE::FARMACIA
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::FARMACIA
description Introduction: Psoriasis is an autoimmune, inflammatory and chronic skin disease in which there is an acceleration of cell growth and proliferation, resulting in erythema and ill-defined lesions, with white and red stains and peeling of the epidermis. Methotrexate (MTX) is one of the drugs for the treatment of systemic use, but there are several side effects. Topical administration may be a strategy to vectorize the release of this drug at the site of action, but as the stratum corneum epidermis is a permeation barrier for hydrophilic drugs, it is necessary to develop vehicles that promote its penetration into the skin. Objective: To evaluate the topical effect of MTX in psoriasis using liquid- crystalline systems (CLs) and hydrogels as vehicles. Method: Study of phase behavior by constructing the ternary phase diagram combining polysorbate 80 (Tween® 80), isopropyl myristate (MIP) and MiliQ water to obtain CLs. The hydrogels tested were based on chitosan (HQS), hydroxypropylmethylcellulose phthalate (HHPMC) and alkylated carbomer (HCA). The samples were characterized by polarized light microscopy (MLP), oscillatory rheology, texture analysis (TPA), solubility of MTX, obtaining the release profile, ex vivo bioadhesion studies and in vivo tests in mice with induction of psoriatic dermatitis. Results: Systems containing surfactant / oil / water in the proportions 60/10/30 and 60/20/20 were characterized as lamellar phases (L1 and L2, respectively) and 50/10/40 and 50/20/30 as hexagonal phases ( H1 and H2, respectively). It was possible to solubilize MTX at a concentration of 2 mg / mL in the CLs and in the HCA hydrogel (pH = 7.4), and 0.1 mg / mL in the HQS hydrogel (pH = 3.5) and not solubilized in HPMCP ( pH = 4.5). Oscillatory rheology showed that hexagonal phases are more elastic than lamellar phases, and HCA with behavior similar to lamellar phases. The TPA test correlated with rheology, but ex vivo bioadhesion showed a better interaction of HCA with swine skin in relation to CLs. The release profile showed that H1 and H2 retained MTX more than L1 and L2, due to their more rigid and organized structure. HCA released more MTX showing that the gelled polymer network retains the drug less. The release profile adjusted for the Weibull mathematical model indicated that the release kinetics is fast and complex. As a proof of principle, in vivo tests showed that CLs promoted a more exacerbated inflammatory effect, but the HCA hydrogel had similar efficacy to dexamethasone. Conclusion: Although studies are still needed to understand the toxicity and safety of the systems, in in vivo tests in mice with imiquimod-induced psoriatic dermatitis, topical application of MTX may be a new approach for the treatment of psoriasis with less side effects and proven efficacy.
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-03-31T18:05:03Z
dc.date.issued.fl_str_mv 2021-02-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv BERNARDES, Maria Tereza Carneiro Paschoal. Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase. 2021. 126 f. Tese ( Doutorado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2021.
dc.identifier.uri.fl_str_mv https://repositorio.unifal-mg.edu.br/handle/123456789/1789
identifier_str_mv BERNARDES, Maria Tereza Carneiro Paschoal. Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase. 2021. 126 f. Tese ( Doutorado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2021.
url https://repositorio.unifal-mg.edu.br/handle/123456789/1789
dc.language.iso.fl_str_mv por
language por
dc.relation.department.fl_str_mv -6425845155986244297
dc.relation.confidence.fl_str_mv 600
600
dc.relation.cnpq.fl_str_mv 6997636413449754996
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Alfenas
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UNIFAL-MG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade Federal de Alfenas
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
instname:Universidade Federal de Alfenas (UNIFAL)
instacron:UNIFAL
instname_str Universidade Federal de Alfenas (UNIFAL)
instacron_str UNIFAL
institution UNIFAL
reponame_str Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
collection Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
bitstream.url.fl_str_mv https://repositorio.unifal-mg.edu.br/bitstreams/c2fcd399-98b2-423c-bd80-b771886f3f16/download
https://repositorio.unifal-mg.edu.br/bitstreams/d2afa41a-f603-478b-bda4-fa823b755a1f/download
https://repositorio.unifal-mg.edu.br/bitstreams/88b5c3a2-1073-4805-9e4f-d4c459047823/download
https://repositorio.unifal-mg.edu.br/bitstreams/930706b1-704d-4f6a-8c2d-45d7f3b2852d/download
https://repositorio.unifal-mg.edu.br/bitstreams/149e65d7-3fca-48fb-a738-4851c798d397/download
https://repositorio.unifal-mg.edu.br/bitstreams/a6122d00-4f43-4bc9-a19e-545bbb5a9ef8/download
https://repositorio.unifal-mg.edu.br/bitstreams/b90da601-8c4a-433e-8d17-86dc54cd4b09/download
bitstream.checksum.fl_str_mv 31555718c4fc75849dd08f27935d4f6b
4afdbb8c545fd630ea7db775da747b2f
d41d8cd98f00b204e9800998ecf8427e
d41d8cd98f00b204e9800998ecf8427e
017f50508d618168b421fed6a54b3014
4314cf716b11b8ef58b64c6e425277b4
6df2fb28d2506c9bf74471ede9dd0f83
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL)
repository.mail.fl_str_mv repositorio@unifal-mg.edu.br
_version_ 1859830899930038272